Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma

Clinical trial NCT01593696 · COMPLETED

Trial details

NCT number: NCT01593696
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

ALL B Cell Lymphoma Leukemia Large Cell Lymphoma Non-Hodgkin Lymphoma

Start date: 2012-06-29
Primary completion: 2016-11-11
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.